Alizapride

From Self-sufficiency
Jump to: navigation, search
Alizapride
File:Alizapride.svg
Systematic (IUPAC) name
N-[(1-allylpyrrolidin-2-yl)methyl]-6-methoxy-1H-benzo[d][1,2,3]triazole-5-carboxamide
Clinical data
Routes of
administration
Oral, IM, IV
Legal status
Legal status
  • ℞ (Prescription only)
Pharmacokinetic data
Biological half-life 3 hours
Excretion Renal
Identifiers
CAS Number 59338-93-1
ATC code A03FA05 (WHO)
PubChem CID 43008
ChemSpider 39202
Chemical data
Formula C16H21N5O2
Molar mass 315.37 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
  (verify)
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Alizapride (Litican, Plitican, Superan, Vergentan) is a dopamine antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting, including postoperative nausea and vomiting. It is structurally related to metoclopramide and other benzamides.[1]

See also

500px

Anon., Drugs Future 1981, 6, 11.

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />



pt:Alizaprida
  1. Bleiberg H, Gerard B, Dalesio O, Crespeigne N, Rozencweig M (1988). "Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial". Cancer Chemother Pharmacol. 22 (4): 316–20. PMID 3048762.